Scott A Rivkees, M.D.
Dr. Rivkees developed a research program that is focused in three major areas: circadian biology, adenosinergic influences on brain injury of prematurity and the discovery of novel pediatric diagnostics and therapeutics. He discovered that the biological clock of preterm infants is responsive to low intensity lighting, leading to new treatment practices for preterm infants. He discovered that A1 adenosine receptor activation induces periventricular white matter injury (PWMI)-the most common neurological disorder affecting premature infants. He has recently discovered adverse effects on body composition and heart function related to prenatal caffeine exposure, findings reported widely in the press. Recently, he started a new research program aimed at the development of novel pediatric diagnostics and therapeutics. Moist recently the Rivkees laboratory has begun to focus on the risks and adverse events associated with Graves’ disease therapy in children and during during pregnancy.